Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00023569 · ClinicalTrials.gov registry record

Electrical Stimulation to Improve Hand Function in Patients With Chronic Stroke

A clinical trial of Cerebrovascular Accident, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
16
Enrollment target
1
Study location

NCT00023569: Completed study of Cerebrovascular Accident, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00023569 is a study of Cerebrovascular Accident that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 16 participants, below the 517-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00023569, a study of Cerebrovascular Accident, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

This study will determine whether an electric shock to the forearm can improve hand function in patients with chronic stroke and, if so, whether the improvement is related to brain reorganization. Some studies indicate that electromyography-triggered neuromuscular electrical stimulation (EMG-triggered NMES) on the forearm improves wrist motor function in patients with chronic stroke. The shock is delivered to the wrist extensor muscle of the forearm, causing greater hand movement than the patient can make on his or her own. The study will determine if the electric shock is more effective given after the patient initiates the hand movement (EMG-triggered NMES) than at times unrelated to patient effort (NMES alone). Stroke patients with muscle weakness on one side of the body may be eligible for this study. The stroke must have occurred at least 12 months before the patient enters the study. Candidates will have a medical history and physical and neurological examinations. Participants will be divided randomly into two groups: EMG-triggered NMES, and NMES alone. For EMG-triggered NMES, two electrodes from the NMES machine and two EMG electrodes are placed on the wrist extensor muscle of the forearm. The patient relaxes the hand, then contracts the wrist extensor muscle to produce movement. This movement triggers the NMES to deliver enough electrical stimulation to produce maximum wrist extension. For NMES alone, only the two NMES electrodes are placed on the forearm. The patient relaxes the hand and stimulation is applied at an intensity to produce full wrist extension without any patient effort. At the first clinic visit, baseline hand function is measured with the following tests: * Wrist extension - wrist extension is measured with a digital instrument called an accelerometer * Pinch power - grip strength between thumb and index finger is measured with a digital pinch analyzer * Jebsen-Taylor hand function - function is evaluated through activities such as movi

Conditions Studied

Study Locations (1)

Maryland

  • National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2001-09
Est. Completion 2003-09

What the finished NCT00023569 record still lists

NCT00023569 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 517-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Cerebrovascular Accident appearing as the primary indexed condition, and to 0 interventions.

NCT00023569 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00023569 about?

NCT00023569 is a clinical study titled "Electrical Stimulation to Improve Hand Function in Patients With Chronic Stroke". This study will determine whether an electric shock to the forearm can improve hand function in patients with chronic stroke and, if so, whether the improvement is related to brain reorganization. Some studies indicate that electromyography-triggered neuromuscular electrical stimulation (EMG-trigger...

What is the current status of trial NCT00023569?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2001-09. Estimated completion is 2003-09.

What conditions does trial NCT00023569 study?

This clinical trial studies the following conditions: Cerebrovascular Accident.

Who is sponsoring clinical trial NCT00023569?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00023569 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebrovascular Accident

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00023569's enrollment target sits among peer trials

16 26th of 26 higher than 1 of 26 other Cerebrovascular Accident trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebrovascular Accident trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00023569, the US trial registry maintained by the National Library of Medicine. NCT00023569 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.